BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 27199054)

  • 1. Outcomes in Moderate Mixed Aortic Valve Disease: Is it Time for a Paradigm Shift?
    Egbe AC; Luis SA; Padang R; Warnes CA
    J Am Coll Cardiol; 2016 May; 67(20):2321-2329. PubMed ID: 27199054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bicuspid and Unicuspid Aortic Valve: Fate of Moderate/Severe Mixed Aortic Valve Disease.
    Egbe AC; Connolly HM; Poterucha JT; Warnes CA
    Congenit Heart Dis; 2017 Jan; 12(1):24-31. PubMed ID: 27375186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of outcome in patients with moderate mixed aortic valve disease.
    Patel KP; McKenna M; Thornton GD; Vandermolen S; Abdulelah ZA; Awad W; Baumbach A; Mathur A; Treibel TA; Lloyd G; Mullen MJ; Bhattacharyya S
    Heart; 2024 Apr; 110(10):740-748. PubMed ID: 38148159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictor of left ventricular dysfunction after aortic valve replacement in mixed aortic valve disease.
    Egbe AC; Warnes CA
    Int J Cardiol; 2017 Feb; 228():511-517. PubMed ID: 27875727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcatheter aortic valve replacement outcomes in mixed aortic valve disease compared to predominant aortic stenosis.
    Heidari B; Al-Hijji MA; Alkhouli MA; Egbe A; Welle G; Eleid MF; Singh M; Gulati R; Rihal C; Lerman A
    Int J Cardiol; 2020 Jan; 299():209-214. PubMed ID: 31402161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of Transcatheter Aortic Valve Replacement in Mixed Aortic Valve Disease.
    Chahine J; Kadri AN; Gajulapalli RD; Krishnaswamy A; Mick S; Perez O; Lak H; Nair RM; Montane B; Tak J; Tuzcu EM; Griffin B; Svensson LG; Harb SC; Kapadia SR
    JACC Cardiovasc Interv; 2019 Nov; 12(22):2299-2306. PubMed ID: 31678084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed aortic valve disease: midterm outcome and predictors of adverse events.
    Egbe AC; Poterucha JT; Warnes CA
    Eur Heart J; 2016 Sep; 37(34):2671-8. PubMed ID: 26994155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Outcomes in Patients With Mixed Aortic Valve Disease and Preserved Left Ventricular Ejection Fraction.
    Isaza N; Desai MY; Kapadia SR; Krishnaswamy A; Rodriguez LL; Grimm RA; Conic JZ; Saijo Y; Roselli EE; Gillinov AM; Johnston DR; Svensson LG; Griffin BP; Popović ZB
    J Am Heart Assoc; 2020 Apr; 9(7):e014591. PubMed ID: 32204665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of asymptomatic adults with combined aortic stenosis and regurgitation.
    Rashedi N; Popović ZB; Stewart WJ; Marwick T
    J Am Soc Echocardiogr; 2014 Aug; 27(8):829-37. PubMed ID: 24874975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical impact of aortic regurgitation after transcatheter aortic valve replacement: insights into the degree and acuteness of presentation.
    Jerez-Valero M; Urena M; Webb JG; Tamburino C; Munoz-Garcia AJ; Cheema A; Dager AE; Serra V; Amat-Santos IJ; Barbanti M; Immè S; Alonso Briales JH; Al Lawati H; Benitez LM; Cucalon AM; Garcia del Blanco B; Revilla A; Dumont E; Barbosa Ribeiro H; Nombela-Franco L; Bergeron S; Pibarot P; Rodés-Cabau J
    JACC Cardiovasc Interv; 2014 Sep; 7(9):1022-32. PubMed ID: 25234675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of diastolic function indices in the risk stratification of patients with mixed aortic valve disease.
    Egbe AC; Khan AR; Boler A; Said SM; Geske JB; Miranda WR; Akintoye E; Connolly HM; Warnes CA; Oh JK
    Eur Heart J Cardiovasc Imaging; 2018 Jun; 19(6):668-674. PubMed ID: 28655164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcatheter aortic valve implantation for mixed versus pure stenotic aortic valve disease.
    Abdelghani M; Cavalcante R; Miyazaki Y; de Winter RJ; Tijssen JG; Sarmento-Leite R; Mangione JA; Abizaid A; Lemos PA; Serruys PW; de Brito FS
    EuroIntervention; 2017 Nov; 13(10):1157-1165. PubMed ID: 28691910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Transcatheter Aortic Valve Replacement on Cardiac Reverse Remodeling and Prognosis in Mixed Aortic Valve Disease.
    Saijo Y; Kusunose K; Takahashi T; Yamada H; Sata M; Sato K; Albakaa N; Ishizu T; Seo Y;
    J Am Heart Assoc; 2024 Feb; 13(4):e033289. PubMed ID: 38362873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular remodelling in bicuspid aortic valve disease.
    Butcher SC; Pio SM; Kong WKF; Singh GK; Ng ACT; Perry R; Sia CH; Poh KK; Almeida AG; González A; Shen M; Yeo TC; Shanks M; Popescu BA; Galian Gay L; Fijałkowski M; Liang M; Tay E; Ajmone Marsan N; Selvanayagam J; Pinto F; Zamorano JL; Pibarot P; Evangelista A; Bax JJ; Delgado V
    Eur Heart J Cardiovasc Imaging; 2022 Nov; 23(12):1669-1679. PubMed ID: 34966913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic relevance of B-type natriuretic peptide in patients with moderate mixed aortic valve disease.
    Onishi H; Naganuma T; Izumo M; Ouchi T; Yuki H; Mitomo S; Nakamura S
    ESC Heart Fail; 2022 Aug; 9(4):2474-2483. PubMed ID: 35543340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of surgical aortic valve replacement for severe aortic stenosis: Incorporation of left ventricular systolic function and stroke volume index.
    Parikh R; Goodman AL; Barr T; Sabik JF; Svensson LG; Rodriguez LL; Lytle BW; Grimm RA; Griffin BP; Desai MY
    J Thorac Cardiovasc Surg; 2015 Jun; 149(6):1558-66.e1. PubMed ID: 25869085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Left Ventricular Ejection Fraction on Clinical Outcomes in Bicuspid Aortic Valve Disease.
    Hecht S; Butcher SC; Pio SM; Kong WKF; Singh GK; Ng ACT; Perry R; Poh KK; Almeida AG; González A; Shen M; Yeo TC; Shanks M; Popescu BA; Gay LG; Fijałkowski M; Liang M; Tay E; Marsan NA; Selvanayagam J; Pinto F; Zamorano JL; Evangelista A; Delgado V; Bax JJ; Pibarot P
    J Am Coll Cardiol; 2022 Sep; 80(11):1071-1084. PubMed ID: 36075677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results of a strategy of aortic valve repair in the pediatric population.
    d'Udekem Y; Siddiqui J; Seaman CS; Konstantinov IE; Galati JC; Cheung MM; Brizard CP
    J Thorac Cardiovasc Surg; 2013 Feb; 145(2):461-7; discussion 467-9. PubMed ID: 23246057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The benefits of early valve replacement in asymptomatic patients with severe aortic stenosis.
    Brown ML; Pellikka PA; Schaff HV; Scott CG; Mullany CJ; Sundt TM; Dearani JA; Daly RC; Orszulak TA
    J Thorac Cardiovasc Surg; 2008 Feb; 135(2):308-15. PubMed ID: 18242258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence, characteristics and prognostic impact of aortic valve disease in patients with heart failure and reduced, mildly reduced, and preserved ejection fraction: An analysis of the ESC Heart Failure Long-Term Registry.
    Shahim B; Shahim A; Adamo M; Chioncel O; Benson L; Crespo-Leiro MG; Anker SD; Coats AJS; Filippatos G; Lainscak M; McDonagh T; Mebazaa A; Piepoli MF; Rosano GMC; Ruschitzka F; Savarese G; Seferovic P; Volterrani M; Crespo Leiro M; Segovia Cubero J; Amir O; Palic B; Maggioni AP; Metra M; Lund LH
    Eur J Heart Fail; 2023 Jul; 25(7):1049-1060. PubMed ID: 37210639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.